The trace aminergic system: a gender-sensitive therapeutic target for IBS?

L Pretorius, C Smith - Journal of Biomedical Science, 2020 - Springer
Due to a lack of specific or sensitive biomarkers, drug discovery advances have been limited
for individuals suffering from irritable bowel syndrome (IBS). While current therapies provide …

Intestinal chemosensitivity in irritable bowel syndrome associates with small intestinal TRPV channel expression

M Grover, A Berumen, S Peters, T Wei… - Alimentary …, 2021 - Wiley Online Library
Background Irritable bowel syndrome (IBS) patients often experience meal‐associated
symptoms. However, the underlying mechanisms are unclear. Aim To determine small …

The application of probe-based confocal laser endomicroscopy as a diagnostic tool in choledochoscopic gallbladder-preserving surgery

B Tang, Y Jia, T Dang, J Chai, Q Wang, Z Chang… - Digestive …, 2023 - karger.com
Abstract Background and Aims: Choledochoscopic gallbladder-preserving surgery (CGPS)
has the advantage of treating benign gallbladder diseases on the premise of gallbladder …

Irritable bowel syndrome and functional dyspepsia: different ends of the same spectrum of intestinal barrier dysfunction?

D Keszthelyi - Official journal of the American College of …, 2021 - journals.lww.com
I read with interest the article from Nojkov et al.(1) describing the role of duodenal barrier
dysfunction as an important underlying mechanism for the development of functional …

Reply to Philpott and Dellon

E Ozdogan, C Arikan - Official journal of the American College of …, 2021 - journals.lww.com
We read the Letter to the Editor by Philpott and Dellon, which was written in response to our
recent work on postliver transplant eosinophilic gastrointestinal disorders (EGID) with great …

Reply to Philpott and Dellon

O Elif, A Cigdem - The American Journal of Gastroenterology, 2021 - search.proquest.com
to the high prevalence (14.7% in the entire cohort and 44% in the endoscopy group) of EGID
found in our pediatric cohort, they reported a period prevalence rate equivalent to that of …